CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±è¼ö°æ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ´ç´¢º´/°©»ó¼±Áúȯ/°ñ´ë»çÁúȯ/±âŸ ³»ºÐºñ´ë»çÁúȯ
  • Á÷ À§: ±³¼ö(¿¬±¸±âȹ½ÇÀå, ´ç´¢º´°©»ó¼±¼¾ÅÍÀå, ³»ºÐºñ³»°úÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
72 ±¹³» ±è¼ö°æ. ´ç´¢º´ ȯÀÚÀÇ Æ÷°ýÀû °ü¸®. J Korean Diabetes 2019;20:170-175  
71 ±¹³» ±è¼ö°æ. °í·ÉÈ­»çȸ, ³ëÀδ索º´ ȯÀÚÀÇ °ü¸®. J Korean Diabetes 2018;19:200-7  
70 ±¹³» ±è±¤ÀÏ, Á¤Çý°æ, ±èâ¿À, ±è¼ö°æ, Á¶ÇöÈ£, ±è´ë¿­, ÇÏ¿ëÂù, Ȳ¼ºÈñ, ¿øÀå¿ø, ÀÓÀ翵, ±èÇöÁ¤, ±èÀç±Ô. ³«»ó¿¹¹æ Áø·áÁöħ. ´ëÇѳ»°úÇÐȸÁö 2015;89:752-80  
69 ÇØ¿Ü Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS; Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea. Diabetes Metab J. 2019 Aug;43(4):398-406.  
68 ÇØ¿Ü Jun JE, Jeong IK, Yu JM, Kim SR, Lee IK, Han KA, Choi SH, Kim SK, Park HK, Mok JO, Lee YH, Kwon HS, Kim SH, Kang HC, Lee SA, Lee CB, Choi KM, Her SH, Shin WY, Shin MS, Ahn HS, Kang SH, Cho JM, Jo SH, Cha TJ, Kim SY, Won KH, Kim DB, Lee JH, Lee MK. Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Diabetes Metab J. 2019 Jun 20. doi: 10.4093/dmj.2018.0265. [Epub ahead of print]  
67 ÇØ¿Ü Kim HJ, An SY, Han SJ, Kim DJ, Hong CH, Kim YH, Shin DH, Kim NH, Seo JA, Ahn YB, Ko SH, Cho YW, Park SW, Kim SK, Kim KW, Kim CS, Lee KW. The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus. J Res Med Sci. 2019 Feb 25;24:17. doi: 10.4103/jrms.JRMS_43_18. eCollection 2019.  
66 ÇØ¿Ü Jeon JY, Kim SK, Kim KS, Song SO, Yun JS, Kim BY, Kim CH, Park SO, Hong S, Seo DH, Seo JA, Noh JH, Kim DJ; DKA Study Group of Gyeonin Branch of the Korean Diabetes Association. Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors. Diabetes Metab. 2019 Oct;45(5):453-457. doi: 10.1016/j.diabet.2019.01.001. Epub 2019 Jan 9.  
65 ÇØ¿Ü Lee K. Park IB, Yu SH, Kim SK, Kim SH, Seo DH, Hong S, Jeon JY, Kim DJ, Kim SW, Choi CS, Lee DH. Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new point on the assessment of diabetic ketoacidosis. Diabetes Metab Syndr Obes 2019;12:1161-71  
64 ÇØ¿Ü Han SJ, Boyko EJ, Kim SK, Fujimoto WY, Kahn SE, Leonetti DL. Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans. Diabetes Metab J 2018;42(6):488-495.  
63 ÇØ¿Ü Choe EY, Lee YH, Choi YJ, Huh BW, Lee BW, Kim SK, Kang ES, Cha BS, Lee EJ, Huh KB, Younossi ZM. Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes. J Gastroenterol Hepatol 2018;33:1082-1091  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729